Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients
…, J Heaf, NH Nielsen, AM Fugleholm… - Journal of internal …, 1991 - Wiley Online Library
One thousand and ten patient years of oral anticoagulant therapy with vitamin‐K‐antagonists
were reviewed with regard to major bleeding complications. The incidence of bleeding that …
were reviewed with regard to major bleeding complications. The incidence of bleeding that …
Standards for health promotion in hospitals: development and pilot test in nine European countries
O Groene, SJ Jorgensen, AM Fugleholm… - International Journal of …, 2005 - emerald.com
Purpose – To describe the process of development of standards for health promotion in
hospitals, including pilot study, method and results. Design/methodology/approach – A set of …
hospitals, including pilot study, method and results. Design/methodology/approach – A set of …
Zinc deficiency and pellagra in alcohol abuse
HF Lorentzen, AM Fugleholm, K Weismann - Ugeskrift for Laeger, 2000 - europepmc.org
We report two cases of nutritional deficiency with skin symptoms associated with excessive
intake of wine and beer, causing respectively pellagra and zinc deficiency. Supplementation …
intake of wine and beer, causing respectively pellagra and zinc deficiency. Supplementation …
Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma
AM Fugleholm, TB Ibsen, L Laxmyr… - European Respiratory …, 1993 - Eur Respiratory Soc
Bambuterol is the first long-acting oral beta 2-agonist with a 24 h effective duration. In order
to investigate the possibility of replacing established treatment modalities with bambuterol …
to investigate the possibility of replacing established treatment modalities with bambuterol …
Embolization of the middle meningeal artery in patients with chronic subdural hematoma—a systematic review and meta-analysis
…, OS Schwartz, R Mikkelsen, K Fugleholm… - Acta …, 2020 - Springer
Background Chronic subdural hematoma (CSDH) remains a neurosurgical condition with
high recurrence rate after surgical treatment. The primary pathological mechanism is …
high recurrence rate after surgical treatment. The primary pathological mechanism is …
Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis
…, P Brastianos, L Poulsgaard, K Fugleholm… - Journal of Neurology …, 2020 - jnnp.bmj.com
Background TERT gene alterations (TERT-alt) have been linked to increased risk of
recurrence in meningiomas, whereas the association to mortality largely remain incompletely …
recurrence in meningiomas, whereas the association to mortality largely remain incompletely …
Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach
Background Chronic subdural haematoma (CSDH) is a pathology that is frequently encountered
by neurosurgeons. Nevertheless, there is a lack of guidelines based on solid evidence. …
by neurosurgeons. Nevertheless, there is a lack of guidelines based on solid evidence. …
Active and passive smoking among personnel at the Bispebjerg Hospital 1992-1999
AD Olsen, AM Fugleholm, S Rasmussen… - Ugeskrift for …, 2000 - europepmc.org
The purpose of this study was to describe changes in smoking behaviour and exposure to
passive smoking among hospital employees at a large Danish University Hospital (Bispebjerg …
passive smoking among hospital employees at a large Danish University Hospital (Bispebjerg …
Proposal of a new grading system for meningioma resection: the Copenhagen Protocol
…, J Skjoth-Rasmussen, L Poulsgaard, K Fugleholm… - Acta …, 2022 - Springer
Introduction The extent of meningioma resection is the most fundamental risk factor for
recurrence, and exact knowledge of extent of resection is necessary for prognostication and for …
recurrence, and exact knowledge of extent of resection is necessary for prognostication and for …
Examination of distal involvement in cisplatin-induced neuropathy in man: An electrophysiological and histological study with particular reference to touch receptor …
A Krarup-Hansen, K Fugleholm, S Helweg-Larsen… - Brain, 1993 - academic.oup.com
Cisplatin is a widely used anti-neoplastic agent with dose-dependent sensory neuropathy
as a major side-effect. The mechanism for the neuropathy is poorly understood; it may be …
as a major side-effect. The mechanism for the neuropathy is poorly understood; it may be …